Pablo Cagnoni and Tony Coles

CRISPR Therapeutics has added Pablo Cagnoni to its board of directors and has named Tony Coles chairman of the board. Cagnoni currently serves as CEO of Tizona Therapeutics and executive chairman of Blade Therapeutics. Prior to that, he held executive positions at Onyx Pharmaceuticals and Novartis Oncology. Cagnoni holds an MD from the University of Buenos Aires School of Medicine. Coles joined CRISPR Therapeutics' board in 2015 and succeeds Bradley Bolzon, managing director of Versant Ventures and founding chairman since 2013.